Hydrafacial Results Presentation Deck
Reconciliation of net income to adjusted EBITDA
($mm)
Net sales
Net income (loss)
Adjusted to exclude the following:
Change in fair value of warrant liability
Amortization expense
Loss on disposal of assets
Stock-based compensation expense
Interest income
Other (income) expense, net
Transaction related costs²
Write-off of discontinued and obsolete product
Severance, restructuring and other³
Litigation related costs
Aggregate adjustment for income taxes
Adjusted net loss
Depreciation expense
Interest expense
Foreign currency (gain) loss, net
Remaining (benefit) expense for income taxes
Adjusted EBITDA
Adjusted EBITDA margin
30
Three months ended March 31,
2022¹
$75.4
$31.5
2023
$86.3
($22.3)
9.1
4.4
0.1
3.6
(4.3)
(0.4)
3.0
2.9
1.0
(2.5)
($5.5)
1.8
3.4
0.9
(1.2)
($0.5)
(0.6%)
(52.1)
3.7
0.8
7.0
0.1
1.0
2.0
(3.6)
($9.5)
1.4
3.4
(0.4)
6.2
$1.2
1.5%
Note: Amounts may not sum due to rounding.
1. Reflects the impact of immaterial revisions to the financial statements.
2. For the three months ended March 31, 2022, such amounts primarily represent direct costs incurred in relation to potential acquisitions.
3. For the three months ended March 31, 2023, such costs represent executive severance, retention awards, and contract termination costs. For the three months ended March 31, 2022, such costs represent personnel costs related to executive
recruiting, executive severance and a CEO sign-on bonus.
BEAUTYHEALTH™View entire presentation